136 related articles for article (PubMed ID: 10757419)
1. Effect of P450 isozyme-selective inhibitors on in-vitro metabolism of retinoic acid by rat hepatic microsomes.
Ahmad M; Nicholls PJ; Smith HJ; Ahmadi M
J Pharm Pharmacol; 2000 Mar; 52(3):311-4. PubMed ID: 10757419
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
[TBL] [Abstract][Full Text] [Related]
4. Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes.
Nadin L; Murray M
Biochem Pharmacol; 1999 Oct; 58(7):1201-8. PubMed ID: 10484078
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
Gardner I; Wakazono H; Bergin P; de Waziers I; Beaune P; Kenna JG; Caldwell J
Carcinogenesis; 1997 Sep; 18(9):1775-83. PubMed ID: 9328175
[TBL] [Abstract][Full Text] [Related]
6. Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids.
Marill J; Capron CC; Idres N; Chabot GG
Biochem Pharmacol; 2002 Mar; 63(5):933-43. PubMed ID: 11911845
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo.
Thapliyal R; Maru GB
Food Chem Toxicol; 2001 Jun; 39(6):541-7. PubMed ID: 11346483
[TBL] [Abstract][Full Text] [Related]
8. Studies of flurbiprofen 4'-hydroxylation. Additional evidence suggesting the sole involvement of cytochrome P450 2C9.
Tracy TS; Marra C; Wrighton SA; Gonzalez FJ; Korzekwa KR
Biochem Pharmacol; 1996 Oct; 52(8):1305-9. PubMed ID: 8937439
[TBL] [Abstract][Full Text] [Related]
9. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
10. Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation.
Martini R; Murray M
Arch Biochem Biophys; 1993 May; 303(1):57-66. PubMed ID: 8489266
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes.
Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T
Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070
[TBL] [Abstract][Full Text] [Related]
12. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
13. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.
Marill J; Cresteil T; Lanotte M; Chabot GG
Mol Pharmacol; 2000 Dec; 58(6):1341-8. PubMed ID: 11093772
[TBL] [Abstract][Full Text] [Related]
14. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
Raner GM; Vaz AD; Coon MJ
Mol Pharmacol; 1996 Mar; 49(3):515-22. PubMed ID: 8643091
[TBL] [Abstract][Full Text] [Related]
16. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
17. Human cytochrome P-450 metabolism of retinals to retinoic acids.
Zhang QY; Dunbar D; Kaminsky L
Drug Metab Dispos; 2000 Mar; 28(3):292-7. PubMed ID: 10681373
[TBL] [Abstract][Full Text] [Related]
18. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
Brandes LJ; Queen GM; LaBella FS
Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
[TBL] [Abstract][Full Text] [Related]
19. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
20. Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation.
McSorley LC; Daly AK
Biochem Pharmacol; 2000 Aug; 60(4):517-26. PubMed ID: 10874126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]